Home

Coelho Rogerio Vivaldi

CIK 1610381 · PRESIDENT AND CEO · last filed 2026-07-07

Coelho Rogerio Vivaldi is a PRESIDENT AND CEO who has filed 36 SEC Form 4 insider transactions across 6 companies since 2014. The most recent filing shows the insider sold $120.0K of CRNX on Jul 7, 2026. Across all open-market trades the lifetime net is −$3.7M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.4M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$2.44M

Companies

6

Total Filings

36

Lifetime Open-Market Net

-$3.69M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CRNX Director 19,225 $83.85 $1.61M -$190.5K 10 2026-07-07
VTRS Director 45,351 $17.87 $810.4K $0 4 2026-03-10
Sigilon Therapeutics, Inc. (SGTX) Delisted PRESIDENT AND CEO 0 $22.47 $0 $0 8 2023-08-11
Bioverativ Inc. (BIVV) Delisted EVP, Chief Global Therapeutics 0 — — $0 5 2018-03-08
Spark Therapeutics, Inc. (ONCE) Delisted Chief Commercial Officer 20,116 — — -$3.75M 6 2016-07-19
NERV President and CEO 5,208 $4.30 $22.4K $250.0K 1 2014-07-09

Recent Filings

36 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-07 CRNX Sell (S) −3,000 -$120.0K EDGAR
2026-07-02 CRNX Notice (144) −6,000 -$232.1K EDGAR
2026-06-22 CRNX Grant (A) +5,925 $0 EDGAR
2026-03-13 CRNX Sell (S) −5,000 -$180.8K EDGAR
2026-03-12 CRNX Notice (144) −5,000 -$184.9K EDGAR
2026-03-10 VTRS Mixed +24,835 $0 EDGAR
2025-06-13 CRNX Grant (A) +6,900 $0 EDGAR
2025-03-10 VTRS Grant (A) — $0 EDGAR
2025-03-05 VTRS Exer (M) +21,691 $0 EDGAR
2024-06-11 CRNX Grant (A) +3,400 $0 EDGAR
Showing 1–10 of 36
Page 1 of 4
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.